Body Perception and Representation in Overgrowth Syndromes, Behavioral Assessment and Neuropsychological Development (Body-PROBAND)

October 17, 2023 updated by: IRCCS Eugenio Medea

Body Representation, Neuropsychological Profile and Socio-emotional Development in Children With Overgrowth Syndromes, With a Specific Focus on Functional Assessment of Patients With Beckwith-Wiedemann Syndrome and Sotos Syndrome

Sotos Syndrome (SS) and Beckwith-Wiedemann Syndrome (BWS) are known as overgrowth syndromes as they involve an excessive growth of the whole body or of specific body parts. Beyond their primary physical problems, people with SS and BWS could present cognitive delay, socio-emotional and social behavior difficulties. For the SS, previous research reported impairments in specific neuropsychological domains and alterations of social behavior. Nevertheless, a description of the neuropsychological and behavioral profile in developmental age is still lacking. For the BWS, only in recent years alterations in social-cognitive development and in social behavior have started to gain attention of clinicians and researchers. However, no study has investigated the neuropsychological and behavioral functioning of children and adolescents with BWS. In this light, this research project aims at providing the first detailed description of the neuropsychological and behavioral profile of children and adolescents with SS and BWS.

Moreover, patients with SS and BWS experience structural alterations of their bodies and are early exposed to invasive diagnostical and medical procedures, which could interfere with the development of body representation. Body representation starts forming early in life through the integration of exteroceptive and interoceptive information, and plays a pivotal role in the social-cognitive development. Given the changes occurring in puberty and the crucial importance of body image in the relationship with peers, adolescence could be seen as a critical period for studying body representation. Thus, this project would investigate body representation at multiple levels (i.e. body image, body schema and interoceptive perception) and evaluate their impact on social-cognitive abilities in adolescents with SS and BWS. It is expected that both the clinical groups show alterations of body representation compared to healthy peers, and that these alterations could associate with impairments in affect recognition and regulation.

Study Overview

Detailed Description

Background and Rationale Sotos Syndrome (SS) and Beckwith-Wiedemann Syndrome (BWS) are known as overgrowth syndromes as they involve alterations in dimensions of the whole body or of specific body parts. SS is characterized by advanced bone age, macrocephaly, characteristic facies and cognitive delay. For the latter aspect, recent studies has described impairments in specific neuropsychological domains and alterations of social behavior. However, this evidence has been gathered in small and non-uniform samples, thus requiring further investigation. Moreover, a description of the neuropsychological and behavioral profile of SS in developmental age is still lacking. BWS is presented with macroglossia, exomphalos, lateralized overgrowth and hyperinsulinism as cardinal features, and is often associated with Wilms tumor and pathologies of internal organs. While the medical care of these primary issues has greatly improved, recently alterations in social-cognitive development and in social behavior have started to gain attention of clinicians and researchers. Nevertheless, no study has investigated the neuropsychological and behavioral functioning of children and adolescents with BWS.

Body representation is a complex, multi-faceted construct encompassing all the processes that allow to perceive, to experience and to be aware of our body. Body representation starts forming from the first months of life through the integration of exteroceptive and interoceptive information, and plays a crucial role in social-cognitive development. Children with SS and BWS experience structural alterations of their bodies and are early exposed to invasive diagnostical and medical procedures, which could interfere with the development of body representation. Given the changes occurring in puberty and the crucial importance of body image in the relationship with peers, adolescence could be seen as a critical period for body representation. Here, multiple levels of body representation (i.e., body image, body schema and interoceptive accuracy) are investigated in adolescents with SS and BWS compared to a control group of peers with typical development.

Aims The current study would provide a full description of the neuropsychological and behavioral profile of children and adolescents with SS and BWS (Aim 1). Moreover, this study protocol aims at investigating alterations of body representation at multiple levels, i.e. body image, body schema and interoceptive perception, and at evaluating their impact on social-cognitive abilities in adolescents with SS and BWS (Aim 2).

Methodologies This observational study involves two distinct assessment procedures, which may be conducted in a single session or in two sessions.

For Aim 1, children with SS and BWS are administered selected subtests of the NEPSY-II, the most adopted battery in developmental age in conditions of typical and atypical development. The NEPSY-II provides a full description of the neuropsychological profile in six different domains (Attention and executive functions, Language, Memory and learning, Sensorimotor functions, Social Perception, Visuospatial skills). Colored and Standard Raven's Matrices are also administered so as to obtain a reliable index of general intellectual functioning. Moreover, a standardized assessment of academic skills is performed by means of specific tests of the Memory and Transfert (MT) group for reading, comprehension and mathematic. Lastly, parents are asked to fulfil a sheet collecting socio-demographic and anamnestic information and two standardized questionnaires: the Child Behavior Check List (CBCL) assessing the presence of emotional-behavioral problems, and the Autistic Quotient (AQ) questionnaire assessing autistic traits related to five areas of functioning (social skills, attention switching, attention to detail, communication and imagination). The entire procedure is administered in a single session of approximately two hours and 30 minutes, in which short breaks between activities (approximately 10 minutes) are allowed so as not to overexert the child.

For Aim 2, adolescents (aged 11-18 years) with SS and BWS and healthy peers of the control group are administered with a self-report questionnaire assessing body image, an ad hoc created experimental task related to body schema, a virtual reality (VR) paradigm of full-body illusion and two psychophysical tasks assessing interoceptive accuracy. The Body Uneasiness Test (BUT) questionnaire consists of 34 items on a 1-5 Likert scale and allows for the assessment of five dimensions related to body image (weight phobia, body image preoccupation, compulsive self-monitoring, avoidance, and depersonalization). The experimental task, administered through a computer, was developed according to recent studies in literature that have assessed body schema changes in relation to peripersonal space and interpersonal distance. Specifically, participants observe inanimate objects or avatars approaching them. In one condition they have to judge whether they could easily reach the objects/avatars (peripersonal space), in the other condition they have to indicate when the object or avatar is perceived as "too close" (interpersonal distance). The full-body illusion paradigm involves the use of a camera placed 2 meters behind the participant and of a VR head mounted display. The back is touched by the experimenter and the image of this action is replayed to the participant synchronously or with a time delay, thus creating an incongruence between visual and haptic information.This paradigm induces an illusory sense of ownership of the virtual body to be elicited more effectively than tasks focused on individual body parts, and reliable as early as 7-8 year old. A short questionnaire adapted from the literature is administered after each condition so as to assess the illusion in terms of sense of ownership over the virtual body, sense of self location, and tactile sensations. In order to assess the ability to perceive interoceptive signals (interoceptive accuracy), participants are administerd a heartbeat perception task, in which they are asked to mentally count the number of their own heartbeats over a certain period of time. Their responses are compared with precise measurements of the heartbeats by means of a wrist-worn device that allows noninvasive determination of heartrate by photoplethysmography. The procedure is repeated in 4 different time intervals administered in random order among participants, without giving feedback on whether or not the responses are correct. In addition, a control task is proposed in which the participant are asked to mentally count the seconds elapsed in 3 time intervals. For both tasks, a visual analogic scale (VAS) is administered at the end of each time interval to assess the degree of confidence in providing the response (0 = totally unsure to 10 = extremely confident). Lastly, in order to assess the difference in heartrate perception at rest and in dynamic conditions, participants are administered the "Jumping Jack Paradigm," recently developed specifically for pediatric age (Schaan et al., 2019). For the baseline condition, participants, sitting in a comfortable position, are asked to indicate on a VAS how "loud" their heart rate feels. In the dynamic condition, participants are asked to jump for 10 s and then indicate again on VAS how loud they feel their heartbeat is. The responses provided on the VAS scales are compared with the heartrate recorded by the wrist-worn device. The physical activity required is minimal, thus posing no danger to participants. At the same time, this procedure facilitates the perception of the pulse and allows its assessment in an ecological and intuitive way, limiting the impact of any cognitive difficulties. The entire procedure is completed in approximately one hour and 30 minutes, inserting intervals of approximately 10 minutes between tasks.

Analysis Plan For the first aim, all variables will be transformed into scaled or standardized scores according to the normative tables for Italian samples, so as to compare performances of the clinical groups with the age-matched population with typical development.

For each clinical group, the neuropsychological and behavioral profile will be estimated using repeated-measures ANOVA models by entering the average scaled scores of each domain of the NEPSY-II and the standardized scores obtained in the behavioral scales of the CBCL questionnaire.

For the second aim, scores obtained in the five dimensions of the BUT questionnaire from the clinical groups will be compared to those of the control group by means of two-tailed Student's t-tests. For the body illusion task, the responses obtained at the questionnaire in the different conditions will be considered.

For the heartbeat perception task, the difference between actual and reported heartbeats will be transformed into an index of interoceptive accuracy according to previous literature. A similar measure will be estimated for the temporal accuracy control task by calculating the difference between actual and counted seconds.

For the experimental tasks, mixed ANOVA models will be used with both between-groups and within-subject factors (social/non-social stimulus for the computer-based behavioral task, synchronous and asynchronous stimulation for the full-body illusion, heart rate/seconds for the psychophysical tasks).

Significant interaction effects will be explored with post-hoc tests. For all analyses, the significance threshold will be set at p ≤ .05. Relationships between experimental task variables and those derived from standardized tests and questionnaires will be analyzed using Pearson's coefficient, correcting the significance threshold for the number of comparisons.

Study Type

Observational

Enrollment (Estimated)

92

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Lombardia
      • Bosisio Parini, Lombardia, Italy, 23842
        • Recruiting
        • Associazione La Nostra Famiglia - IRCCS Eugenio Medea
        • Contact:
        • Principal Investigator:
          • Rosario Montirosso

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

For Aim 1 and 2 participants with SS and BWS aged 5-18 years will be recruited in collaboration with AIBWS and ASSI Gulliver, associations dedicated to families of patients with SS and BWS. For Aim 2, adolescents with typical development will be recruited in local schools.

Description

Children and Adolescents with SS and BWS

Inclusion Criteria:

  • diagnosis of Sotos Syndrome/Beckwith-Wiedemann Syndrome

Exclusion Criteria:

  • severe motor and sensorial deficits that could interfere with tasks execution

Adolescents with typical development

Exclusion Criteria:

  • any neurological or psychiatric conditions (e.g., learning disability, behavioral disorders etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Sotos Syndrome
Children and adolescents with Sotos Syndrome
Participants with SS and BWS are administered with selected subtests assessing six different neuropsychological domains
Parents of participants with SS and BWS are administered with questionnaires assessing behavioral problems and autistic traits
A questionnaire, a computer-based task, a body-illusion paradigm and two psychophysical tasks assessing diverse levels of body perception and representation. These tasks are administered to adolescents of the three groups
Beckwith-Wiedemann Syndrome
Children and adolescents with Beckwith-Wiedemann Syndrome
Participants with SS and BWS are administered with selected subtests assessing six different neuropsychological domains
Parents of participants with SS and BWS are administered with questionnaires assessing behavioral problems and autistic traits
A questionnaire, a computer-based task, a body-illusion paradigm and two psychophysical tasks assessing diverse levels of body perception and representation. These tasks are administered to adolescents of the three groups
Control group
Adolescents with typical development
A questionnaire, a computer-based task, a body-illusion paradigm and two psychophysical tasks assessing diverse levels of body perception and representation. These tasks are administered to adolescents of the three groups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neuropsychological domains (Attention and Executive Functions, Language, Memory and Learning, Sensorimotor Functions, Social Perception; Visual-Spatial Functions)
Time Frame: At the recruitment - 1 session of 2/2.30 hours
Mean scaled scores of each domain. Scaled scores range from 1 to 20, with mean = 10 and standard deviation (SD) = 3. Scores lower than 4 indicate specific difficulties.
At the recruitment - 1 session of 2/2.30 hours
Emotional-behavioral problems
Time Frame: At the recruitment - 1 session of 10 minutes
Standardized scores at the the Child Behavior Check List. Standardized scores are reported with mean = 50 and SD = 10. Scores higher than 64 indicate possible problems, scores higher than 69 indicate clinical problems
At the recruitment - 1 session of 10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Uneasiness Test questionnaire
Time Frame: At the recruitment- 1 session of 15 minutes
Mean scores obtained in the five dimensions of Body image. Higher scores indicate higher problems.
At the recruitment- 1 session of 15 minutes
Peripersonal space and interpersonal distance
Time Frame: At the recruitment- 1 session of 20 minutes
Peripersonal space and interpersonal distance in meters with social and non-social stimuli (avatar and objects) presented through the computer-based task
At the recruitment- 1 session of 20 minutes
Full-body illusion
Time Frame: At the recruitment- 1 session of 30 minutes
Scores at the VAS assessing sense of ownership overt the virtual body, sense of self-location and tactile sensations. Higher scores indicate higher sense of ownership, self-location and tactile sensations over the virtual body.
At the recruitment- 1 session of 30 minutes
Heartbeat perception task and time estimation task
Time Frame: At the recruitment- 1 session of 15 minutes
Difference between self-perceived and device-recorded heartbeats/seconds
At the recruitment- 1 session of 15 minutes
Jumping Jack Paradigm
Time Frame: At the recruitment- 1 sessions of 10 minutes
Difference between recorded heartbeats and scores at the VAS assessing perceived heartbeats at rest and after physical activity. Higher differences represent lower interoceptive accuracy
At the recruitment- 1 sessions of 10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 28, 2021

Primary Completion (Estimated)

October 31, 2023

Study Completion (Estimated)

December 31, 2023

Study Registration Dates

First Submitted

July 21, 2021

First Submitted That Met QC Criteria

July 28, 2021

First Posted (Actual)

August 6, 2021

Study Record Updates

Last Update Posted (Actual)

October 18, 2023

Last Update Submitted That Met QC Criteria

October 17, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Image

Clinical Trials on NEPSY-II

3
Subscribe